quinacrine has been researched along with Cancer of Pancreas in 5 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Quinacrine is a repositioned drug with an anticancer activity but suffers a limited ability to reach tumor cells." | 1.62 | Undaria pinnatifida fucoidan nanoparticles loaded with quinacrine attenuate growth and metastasis of pancreatic cancer. ( Abdallah, OY; Bary, AA; Elnaggar, YSR; Etman, SM; Mehanna, RA, 2021) |
| "Quinacrine is an antimalarial drug that was repositioned for treatment of cancer." | 1.56 | Lactoferrin/Hyaluronic acid double-coated lignosulfonate nanoparticles of quinacrine as a controlled release biodegradable nanomedicine targeting pancreatic cancer. ( Abdallah, OY; Elnaggar, YSR; Etman, SM; Mehanna, RA, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Etman, SM | 2 |
| Abdallah, OY | 2 |
| Mehanna, RA | 2 |
| Elnaggar, YSR | 2 |
| Bary, AA | 1 |
| Imaida, K | 1 |
| Furukawa, F | 1 |
| Nishikawa, A | 1 |
| Imazawa, T | 1 |
| Kasahara, K | 1 |
| Takahashi, M | 1 |
| Kreuser, ED | 1 |
1 review available for quinacrine and Cancer of Pancreas
| Article | Year |
|---|---|
[Malignant pleural effusions. Pathophysiology, diagnosis and therapy].
Topics: Absorption; Amylases; Antineoplastic Agents; Breast Neoplasms; Bronchial Neoplasms; Capillary Permea | 1985 |
4 other studies available for quinacrine and Cancer of Pancreas
| Article | Year |
|---|---|
Lactoferrin/Hyaluronic acid double-coated lignosulfonate nanoparticles of quinacrine as a controlled release biodegradable nanomedicine targeting pancreatic cancer.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Cell Movement; Cell Surv | 2020 |
Undaria pinnatifida fucoidan nanoparticles loaded with quinacrine attenuate growth and metastasis of pancreatic cancer.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Male; Mice; Mice, I | 2021 |
Undaria pinnatifida fucoidan nanoparticles loaded with quinacrine attenuate growth and metastasis of pancreatic cancer.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Male; Mice; Mice, I | 2021 |
Undaria pinnatifida fucoidan nanoparticles loaded with quinacrine attenuate growth and metastasis of pancreatic cancer.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Male; Mice; Mice, I | 2021 |
Undaria pinnatifida fucoidan nanoparticles loaded with quinacrine attenuate growth and metastasis of pancreatic cancer.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Male; Mice; Mice, I | 2021 |
Delayed toxicity associated with morphological changes in animal experiments.
Topics: Animals; Carcinogenicity Tests; Carcinogens; Drug Evaluation, Preclinical; Male; Pancreatic Neoplasm | 1996 |
Enhancing effects of quinacrine on development of hepatopancreatic lesions in N-nitrosobis(2-oxopropyl)amine-initiated hamsters.
Topics: Animals; Antineoplastic Agents; Body Weight; Carcinogens; Cricetinae; Drug Synergism; Female; Kidney | 1998 |